Q1 2026 Earnings Call Transcript August 19, 2025 Medtronic plc beats earnings expectations. Reported EPS is $1.26, ...

Medtronic (MDT) recently reported its Q1 FY2026 earnings, showing an increase in sales to $8,578 million, while net income ...

Medtronic PLC (MDT) reports robust growth across key segments, raises full-year EPS guidance, and outlines strategic ...

Medtronic (MDT) stock in focus as the company raises FY2025 earnings outlook amid Q1 outperformance and reduced tariff impact ...

Medtronic reported strong first-quarter 2026 results, with sales hitting $8.58 billion, surpassing the consensus estimate of ...

Medtronic ( ($MDT) ) has released its Q1 earnings. Here is a breakdown of the information Medtronic presented to its investors. Medtronic plc, ...

Medtronic develops and manufactures a wide range of medical devices, including implantable cardiac pacemakers, heart valves, neurostimulation systems, insulin pumps, and surgical robotics platforms.

Medtronic (NYSE:MDT) reports Q1 earnings on Aug 19. Can it sustain revenue growth amid EPS concerns? Learn about key trends, ...

FQ1 results and guidance update did not spark a rally in the share price. Still, they did affirm a robust outlook that ...

In the first quarter of fiscal year 2026, Medtronic saw growth in its overall revenue and neuroscience portfolio, according to financial results posted Aug. 19. Five things to know: 1. Total revenue ...

The medical device company posted revenue of $8.58 billion in the period, also beating Street forecasts. Eleven analysts surveyed by Zacks expected $8.37 billion. Medtronic expects full-year earnings ...

Medtronic’s adjusted operating margin slid 40 bps to 24.4% in Q1. Medtronic’s bottom line of $1.23 on an adjusted basis was slightly above the $1.20 figure it reported in the prior-year quarter.